501 Prospective UGT1A1 genotyping in a phase I study of safety and pharmacokinetics of liposome encapsulated SN-38 (LE-SN38)
LoRusso P, Fishman M, Kraut E, Gordon M, Elsayed Y, Steinberg J, Nieves J, Wanaski S, Dul J, Sherman J. 501 Prospective UGT1A1 genotyping in a phase I study of safety and pharmacokinetics of liposome encapsulated SN-38 (LE-SN38). European Journal Of Cancer Supplements 2004, 2: 153. DOI: 10.1016/s1359-6349(04)80509-3.Peer-Reviewed Original Research